Top news of June: FDA bans marketing of Juul products; pulse oximetry accuracy; COVID-19

The Healio Editors compiled the most-read news in pulmonology posted in May.

Highlights include the FDA’s issue of marketing denial orders to Juul Labs for all of their vaping devices and related products in the U.S.; the U.S. News and World Report’s Best Children’s Hospitals for pulmonology and lung surgery; a study that identified eight signals for asthma-COPD overlap; brensocatib failed to improve COVID-19 clinical status; and more.

Read these articles, and others, below, in no particular order.

FDA denies authorization to market Juul vaping products

In late June, the FDA issued marketing denial orders to Juul Labs for all of their vaping devices and related products. As a result, the company must stop selling and distributing these products, and those currently on the U.S. market must be removed. Read more

Texas Children’s Hospital ranked No. 1 in US for pulmonology and lung surgery

Texas Children’s Hospital ranked No. 1 on U.S. News & World Report‘s list of Best Children’s Hospitals for pulmonology and lung surgery. Read more

Racial, ethnic biases in pulse oximetry accuracy may have delayed COVID-19 treatment for some

Ongoing use of CPAP may reduce mortality risk in people with obstructive sleep apnea

Ongoing continuous positive airway pressure use in the first year after starting therapy was associated with lower risk for all-cause mortality in patients with obstructive sleep apnea, according to research published in Chest. Read more

Overuse of asthma rescue inhalers common, varies among practices

Rates of overprescribing of short-acting beta agonist asthma inhalers remain high and vary significantly among practices, according to new data published in the British Journal of General Practice. Read more

New lung cancer guidelines reduced some screening disparities

New lung cancer screening guidance from the U.S. Preventive Services Task Force, which lowered the age for inclusion and intensity of smoking to qualify as high risk, resulted in an increase in the proportion of Black individuals screened. Read more

Historical redlining in California linked to worse COVID-19 outcomes

SAN FRANCISCO — Residents affected by historical redlining in California communities had worse COVID-19 outcomes, according to new data presented at the American Thoracic Society International Conference. Read more

Brensocatib did not improve clinical status in patients with severe COVID-19

SAN FRANCISCO — Brensocatib, an investigational oral inhibitor of dipeptidyl peptidase 1, did not improve the clinical status of patients hospitalized with severe COVID-19 at 29 days, according to results of the STOP-COVID19 trial. Read more

Study highlights differences in perception of health care delivery by race/ethnicity

SAN FRANCISCO — A new study highlights disparities in perceptions of health care satisfaction among Black and Hispanic patients compared with white patients, according to data presented at the American Thoracic Society International Conference. Read more

Study identifies eight signals for asthma-COPD overlap

A new study identified eight signals for asthma-COPD overlap that researchers said appear to represent loci that predispose patients to type 2 inflammation and thus serious long-term consequences of asthma, researchers reported in Chest. Read more